Taiwanese Clinical Laboratory Instrumentation Markets


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

The clinical laboratory instrumentation (CLI) market in Taiwan is a mature market that is approaching saturation. Taiwan has one of the best healthcare systems in Asia Pacific after Japan and offers both modern and comprehensive medical services to its population. The CLI market in Taiwan was valued at approximately $67.0 million in 2005 and is expected to grow by about 4.0 percent in 2006. The market is expected to experience of compound annual growth rate (CAGR) of 5.9 percent driven by strong growth in molecular diagnostics product segment. Growth in core market segments of clinical chemistry, immunochemistry and hematology remain modest with growth expected to pick up towards the end of the forecast period.

Table of Contents

Taiwanese Clinical Laboratory Instrumentation Markets, Research Scope and MethodologyScope and SegmentationResearch ScopeMarket SegmentationResearch MethodologyMethodologyKey Definitions and AbbreviationsTaiwanese Clinical Laboratory Instrumentation Markets, Clinical Laboratory Instrumentation Market in TaiwanMarket OverviewIntroductionMarket Engineering AnalysisMarket DynamicsIndustry ChallengesMarket DriversMarket RestraintsTaiwanese Clinical Laboratory Instrumentation Markets, Revenue Forecasts for Clinical Laboratory Instrumentation Markets in TaiwanMarket ForecastsTotal Revenues ForecastsClinical Chemistry Revenue ForecastsImmunochemistry Revenue ForecastsHematology Revenue ForecastsUrinalysis Revenue ForecastsMolecular Diagnostic Revenue ForecastsProduct Segment LifecycleTechnology TrendsAutomated AnalyzersIntegrated AnalyzersTotal Laboratory AutomationTaiwanese Clinical Laboratory Instrumentation Markets, Competitive AnalysisCompetitive StructureCompetitive StructureCompetitive LandscapeClinical ChemistryImmunochemistryHematologyUrinalysisMolecular DiagnosticsTaiwanese Clinical Laboratory Instrumentation Markets, Strategic Recommendations Strategic RecommendationsFocus on Instrument Upgrades and Replacements in Existing AccountsPromote Enhanced Levels of Automation and IntegrationMaintain and Capitalize on Good Customer Relationships and High Service QualityTaiwanese Clinical Laboratory Instrumentation Markets, Decision Support DatabasesDecision Support DatabaseTotal Healthcare ExpenditurePer Capita Healthcare ExpenditurePopulation above 65

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.